By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Foamix Pharmaceuticals, Ltd. 

2 Holzman Street
Weizmann-Science Park
Rehovot    76704  Israel
Phone: 972-8-9316233 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Foamix Pharma (FOMX) Announces Completion Of Patient Enrollment In Phase 3 Acne Trials For Minocycline Foam FMX101 11/28/2016 6:43:09 AM
Foamix Pharma (FOMX) Reports Third Quarter 2016 Financial Results and Provides Business Update 11/16/2016 8:56:52 AM
Foamix Pharma (FOMX) Announces Pricing Of Its $57 Million Follow-On Offering Of Ordinary Shares 9/28/2016 7:43:04 AM
Foamix Pharma (FOMX) Announces Proposed Follow-On Offering Of Ordinary Shares 9/28/2016 6:50:49 AM
Foamix Pharma (FOMX) Announces Positive Topline Results From Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam For Moderate-To-Severe Papulopustular Rosacea 9/12/2016 8:37:48 AM
Foamix Pharma (FOMX) To Announce Topline Results In Phase 2 Clinical Trial Of FMX-103 Minocycline Topical Foam For Moderate-To-Severe Papulopustular Rosacea 9/9/2016 6:37:49 AM
Foamix Pharma (FOMX) Reports Second Quarter 2016 Financial Results And Provides Business Update 8/10/2016 10:50:59 AM
Foamix Pharma (FOMX) Announces Completion Of Enrollment In Phase II Clinical Trial Of Minocycline Foam (FMX103) For Treatment Of Papulopustular Rosacea 5/3/2016 7:45:40 AM
Foamix Pharmaceuticals, Ltd. (FOMX) To Host Conference Call & Webcast To Discuss Topline Results From Phase II Study Of FDX-104 In Acneiform Rash Associated With Targeted Antibody Treatments For Colon And Head And Neck Cancers 12/3/2015 7:20:37 AM
Shares Jump as Foamix Pharma (FOMX)'s FDX104 Shows Efficacy in Phase II Study 12/3/2015 6:04:07 AM
1234567
//-->